Freedom4um

Status: Not Logged In; Sign In

National News
See other National News Articles

Title: Issues with CDC Test for Covid-19
Source: [None]
URL Source: https://www.investmentwatchblog.com ... es-with-cdc-test-for-covid-19/
Published: Feb 19, 2020
Author: Mike Rivero
Post Date: 2020-02-19 19:35:00 by Horse
Keywords: None
Views: 427
Comments: 1

This is a copy and paste from CDC web site www.cdc.gov/coronavirus/2019-ncov/about/testing.html

The way I read this is that there is a problem with the reagent in the “diagnostic panel test”… the test that should be but is now NOT being used by local state health authorities… Which means all the tests for the whole USA has to go through the CDC… PLEASE TELL ME I HAVE THIS WRONG!

“CDC has developed a new laboratory test kit for use in testing patient specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. The test kit is called the “Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel.” It is intended for use with the Applied Biosystems 7500 Fast DX Real-Time PCR Instrument with SDS 1.4 software. This test is intended for use with upper and lower respiratory specimens collected from persons who meet CDC criteria for COVID-19 testing. CDC’s test kit is intended for use by laboratories designated by CDC as qualified, and in the United States, certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. The test kits also will be shipped to qualified international laboratories, such as World Health Organization (WHO) Global Influenza Surveillance Response System (GISRS) laboratories. The test will not be available in U.S. hospitals or other primary care settings. The kits will be distributed through the International Reagent Resourceexternal icon (IRR)

On Monday, February 3, 2020, CDC submitted an Emergency Use Authorization (EUA) package to the U.S. Food and Drug Administration (FDA) in order to expedite FDA permitted use of the CDC diagnostic panel in the United States. The EUA process enables FDA to consider and authorize the use of unapproved, but potentially life-saving medical or diagnostic products during a public health emergency. The U.S. Secretary of Health and Human Services declared the SARS-CoV-2 virus a U.S. public health emergency on Friday, January 31, 2020. FDA issued the EUA on February 4, 2020. IRR began distribution of the test kits to states, but shortly thereafter performance issues were identified related to a problem in the manufacturing of one of the reagents which led to laboratories not being able to verify the test performance. CDC is remanufacturing the reagents with more robust quality control measures. New tests will be distributed once this issue has been addressed. CDC continues to perform initial and confirmatory testing.”


Poster Comment:

CDC is not up to the job.

Post Comment   Private Reply   Ignore Thread  


TopPage UpFull ThreadPage DownBottom/Latest

#1. To: Horse (#0)

I had a medical blood test about a month ago (not for covid-19] and have not yet received the results. The problem is that the lab is unable to obtain the necessary reagents to run the tests. I believe the problem is that the supplier for the reagents is China. They don't know when/if they'll get them. I'll know more details later.

Some companies in the US are going to have to ramp up to start producing some of these reagents/chemical solutions.

ratcat  posted on  2020-02-20   0:43:52 ET  Reply   Trace   Private Reply  


TopPage UpFull ThreadPage DownBottom/Latest